Insulin-like growth factor receptor polymorphism defines clinical outcome in estrogen receptor-positive breast cancer patients treated with tamoxifen
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Insulin-like growth factor receptor polymorphism defines clinical outcome in estrogen receptor-positive breast cancer patients treated with tamoxifen
Authors
Keywords
-
Journal
PHARMACOGENOMICS JOURNAL
Volume 14, Issue 1, Pages 28-34
Publisher
Springer Nature
Online
2013-03-05
DOI
10.1038/tpj.2013.8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A phase I study of the oral mTOR inhibitor ridaforolimus (RIDA) in combination with the IGF-1R antibody dalotozumab (DALO) in patients (pts) with advanced solid tumors.
- (2017) S. Di Cosimo et al. JOURNAL OF CLINICAL ONCOLOGY
- Dual inhibition of IGFR and mTOR pathways.
- (2017) A. Naing et al. JOURNAL OF CLINICAL ONCOLOGY
- Cancer treatment and survivorship statistics, 2012
- (2012) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Randomized Phase II Trial of Everolimus in Combination With Tamoxifen in Patients With Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Metastatic Breast Cancer With Prior Exposure to Aromatase Inhibitors: A GINECO Study
- (2012) Thomas Bachelot et al. JOURNAL OF CLINICAL ONCOLOGY
- LMTK3 expression in breast cancer: association with tumor phenotype and clinical outcome
- (2011) Justin Stebbing et al. BREAST CANCER RESEARCH AND TREATMENT
- A Kinome-Wide Screen Identifies the Insulin/IGF-I Receptor Pathway as a Mechanism of Escape from Hormone Dependence in Breast Cancer
- (2011) E. M. Fox et al. CANCER RESEARCH
- Kinome screening for regulators of the estrogen receptor identifies LMTK3 as a new therapeutic target in breast cancer
- (2011) Georgios Giamas et al. NATURE MEDICINE
- Everolimus in Postmenopausal Hormone-Receptor–Positive Advanced Breast Cancer
- (2011) José Baselga et al. NEW ENGLAND JOURNAL OF MEDICINE
- A 3'-Untranslated Region Polymorphism in IGF1 Predicts Survival of Non-Small Cell Lung Cancer in a Chinese Population
- (2010) M. Zhang et al. CLINICAL CANCER RESEARCH
- Germline Polymorphisms in Genes Involved in the IGF1 Pathway Predict Efficacy of Cetuximab in Wild-type KRAS mCRC Patients
- (2010) T. Winder et al. CLINICAL CANCER RESEARCH
- American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer
- (2010) M. Elizabeth H. Hammond et al. JOURNAL OF CLINICAL ONCOLOGY
- Insulin-like growth factor 1 (IGF1), IGF binding protein 3 (IGFBP3), and breast cancer risk: pooled individual data analysis of 17 prospective studies
- (2010) LANCET ONCOLOGY
- An integrative scoring system for ranking SNPs by their potential deleterious effects
- (2009) P. H. Lee et al. BIOINFORMATICS
- Association of IGF1 and IGFBP3 polymorphisms with colorectal polyps and colorectal cancer risk
- (2009) Elisabeth Feik et al. CANCER CAUSES & CONTROL
- Membrane oestrogen receptor α signalling to cell functions
- (2009) Ellis R. Levin JOURNAL OF PHYSIOLOGY-LONDON
- Activation of ErbB3, EGFR and Erk is essential for growth of human breast cancer cell lines with acquired resistance to fulvestrant
- (2008) Thomas Frogne et al. BREAST CANCER RESEARCH AND TREATMENT
- Genetic Polymorphisms Involved in Insulin-like Growth Factor (IGF) Pathway in Relation to Mammographic Breast Density and IGF Levels
- (2008) C. Diorio et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Tamoxifen Resistance in Breast Tumors Is Driven by Growth Factor Receptor Signaling with Repression of Classic Estrogen Receptor Genomic Function
- (2008) S. Massarweh et al. CANCER RESEARCH
- Insulin-Like Growth Factor-I Activates Gene Transcription Programs Strongly Associated With Poor Breast Cancer Prognosis
- (2008) Chad J. Creighton et al. JOURNAL OF CLINICAL ONCOLOGY
- IGF and Insulin Receptor Signaling in Breast Cancer
- (2008) Antonino Belfiore et al. JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA
- Crosstalk Between IGF1R and Estrogen Receptor Signaling in Breast Cancer
- (2008) Dedra H. Fagan et al. JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA
- Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 100-month analysis of the ATAC trial
- (2008) LANCET ONCOLOGY
- Genetic variation in insulin-like growth factors and brain tumor risk
- (2008) Stefan Lönn et al. NEURO-ONCOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now